BOOTHBAY FUND MANAGEMENT, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$185,000
-28.8%
32,324
+13.6%
0.00%
-33.3%
Q4 2021$260,000
-35.6%
28,460
-24.8%
0.01%
-45.5%
Q3 2021$404,000
+152.5%
37,828
+266.6%
0.01%
+120.0%
Q2 2021$160,000
+3.2%
10,318
-21.8%
0.01%
-61.5%
Q1 2020$155,000
-41.5%
13,200
+21.6%
0.01%
-89.7%
Q3 2015$265,00010,8540.13%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders